Search - tctmd.com

Displaying 721 - 740 of 1109

Sort: Relevancy | Date

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Daily News

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

L.A. McKeown

January 01, 2014

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Daily News

Notable Descenso del Uso de PCI y Variación Geográfica en el Manejo de la Enfermedad Estable tras el Ensayo COURAGE

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Daily News

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

December 05, 2013

News Daily News

El Tratamiento con Testosterona Post-Angiografía aumenta los Episodios Cardiovasculares en Varones de Alto Riesgo

December 05, 2013

News Daily News

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

December 02, 2013

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

News Daily News

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

November 21, 2013

News Daily News

Registro: Los Dispositivos de Cierre Reducen las Complicaciones Vasculares tras PCI Transfemorales

November 21, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Industry News

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

Advertisement

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Notable Descenso del Uso de PCI y Variación Geográfica en el Manejo de la Enfermedad Estable tras el Ensayo COURAGE

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

El Tratamiento con Testosterona Post-Angiografía aumenta los Episodios Cardiovasculares en Varones de Alto Riesgo

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

Registry: Closure Devices Reduce Vascular Complications After Transfemoral PCI

Registro: Los Dispositivos de Cierre Reducen las Complicaciones Vasculares tras PCI Transfemorales

OPTIMIZE: 3-Month DAPT Safe with ZES

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

Two Trials to Assess TAVR in Moderate-Risk Patients

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

Novel Ischemia Measurement Strategies Show Potential vs. FFR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content